Literature DB >> 1933596

Lifelong calcium intake and prevention of bone fragility in the aged.

R P Heaney1.   

Abstract

Primary prevention of osteoporosis involves achieving the full genetic potential for bone mass. Secondary prevention is concerned with protecting what bone mass a woman may have at her current age. Calcium plays an important role in both. Calcium requirement varies with stage of growth, with physiological drains (e.g., pregnancy and lactation), and with factors that influence absorption and excretory loss (e.g., gonadal hormone status and sodium and protein intakes). The evidence is strong that prevailing calcium intakes contribute to the low bone mass component of osteoporotic fragility and that increases in intake would reduce the osteoporotic fracture burden. At the same time it needs to be emphasized that bone health is a multifactorial affair and that meeting calcium requirements alone will neither guarantee optimal bone growth nor protect against bone loss if other critical factors are missing. For example, calcium affords only minimal protection against either immobilization or estrogen withdrawal bone loss. Thus, while assuring an adequate calcium intake remains a sound strategy, it cannot be considered a total preventive for osteoporosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1933596     DOI: 10.1007/bf02555087

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  29 in total

1.  The estimation of calcium requirement: a re-examination.

Authors:  I LEITCH; F C AITKEN
Journal:  Nutr Abstr Rev       Date:  1959-04

2.  Factors that influence peak bone mass formation: a study of calcium balance and the inheritance of bone mass in adolescent females.

Authors:  V Matkovic; D Fontana; C Tominac; P Goel; C H Chesnut
Journal:  Am J Clin Nutr       Date:  1990-11       Impact factor: 7.045

Review 3.  Osteoporotic fracture space: an hypothesis.

Authors:  R P Heaney
Journal:  Bone Miner       Date:  1989-04

4.  En recherche de la différence (P less than 0.05).

Authors:  R P Heaney
Journal:  Bone Miner       Date:  1986-04

5.  Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.

Authors:  B L Riggs; S F Hodgson; W M O'Fallon; E Y Chao; H W Wahner; J M Muhs; S L Cedel; L J Melton
Journal:  N Engl J Med       Date:  1990-03-22       Impact factor: 91.245

Review 6.  The calcium controversy: finding a middle ground between the extremes.

Authors:  R P Heaney
Journal:  Public Health Rep       Date:  1989 Sep-Oct       Impact factor: 2.792

7.  The relative contributions of age and years since menopause to postmenopausal bone loss.

Authors:  B E Nordin; A G Need; B E Chatterton; M Horowitz; H A Morris
Journal:  J Clin Endocrinol Metab       Date:  1990-01       Impact factor: 5.958

8.  Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study.

Authors:  D P Kiel; D T Felson; J J Anderson; P W Wilson; M A Moskowitz
Journal:  N Engl J Med       Date:  1987-11-05       Impact factor: 91.245

9.  Calcium absorption from calcium carbonate and a new form of calcium (CCM) in healthy male and female adolescents.

Authors:  J Z Miller; D L Smith; L Flora; C Slemenda; X Y Jiang; C C Johnston
Journal:  Am J Clin Nutr       Date:  1988-11       Impact factor: 7.045

10.  Menopausal changes in calcium balance performance.

Authors:  R P Heaney; R R Recker; P D Saville
Journal:  J Lab Clin Med       Date:  1978-12
View more
  3 in total

1.  Bone mineral density in coeliac disease.

Authors:  J R Walters
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

2.  Low-calcium diet prevents fructose-induced hyperinsulinemia and ameliorates the response to glucose load in rats.

Authors:  Anna Voznesenskaya; Michael G Tordoff
Journal:  Nutr Metab (Lond)       Date:  2015-10-29       Impact factor: 4.169

3.  Effectiveness of thiazides on serum and urinary calcium levels and bone mineral density in patients with osteoporosis: a systematic review and meta-analysis.

Authors:  Lei Cheng; Keyan Zhang; Zhenyong Zhang
Journal:  Drug Des Devel Ther       Date:  2018-11-14       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.